Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Sarana Menara Nusantara Tbk. (TOWR)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Sarana Menara Nusantara Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sarana Menara Nusantara Tbk. diperdagangkan di Rp454 (kapitalisasi pasar 27,07 T, volume 24 jam 48,95 jt). Perbedaan utamanya: Sarana Menara Nusantara Tbk. jauh lebih besar — sekitar 259,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TOWR | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 27,07 T |
Volume | — | 48,95 jt |
Lot | — | 489,54 rb |
Perputaran | — | 22,1 M |
Harga Rata-rata | — | 451,36 |
Nilai Transaksi | — | 22,1 M |
Harga Ekuilibrium Indikatif | — | 454 |
Volume Ekuilibrium Indikatif | — | 12,16 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Sarana Menara Nusantara Tbk.
PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering
Selengkapnya di halaman TOWR →
